EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy.
Biochim Biophys Acta Rev Cancer
; 1878(1): 188827, 2023 01.
Article
in En
| MEDLINE
| ID: mdl-36309124
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
Head and Neck Neoplasms
Limits:
Humans
Language:
En
Journal:
Biochim Biophys Acta Rev Cancer
Year:
2023
Type:
Article
Affiliation country:
United States